DEAL with Obesity Act of 2024
See how your representatives voted on this bill.
DeepSyte matches this bill to the issues you care about and shows whether your reps' votes line up — not party, not press releases. Take the 2-minute values quiz to see your alignment.
Alignment with your views
Sign in and take the values quiz to see how this bill lines up with what you've said.
Summary
The DEAL with Obesity Act of 2024 amends Medicare Part D to provide coverage of weight loss medications (GLP-1 receptor agonists and similar drugs approved for weight reduction) for dual-eligible individuals—those enrolled in both Medicare and Medicaid. Beginning in 2026, the bill would require Medicare Part D plans to cover these weight loss agents for eligible beneficiaries, potentially reducing out-of-pocket costs from $900–$1,350 per month to approximately $25 per month.
Values analysis
Sign in and take the values quiz to get a personalized read on how this bill lines up with your positions.
How your representatives voted
Sign in to see how your representatives voted on this bill.